Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1-(4-Cyanophenyl)-1H-pyridin-2-one is a pyridinone derivative with the molecular formula C12H8N2O. It is a yellow powder that exhibits potential applications in the fields of medicine and drug discovery due to its unique structure and properties.

444002-96-4

Post Buying Request

444002-96-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

444002-96-4 Usage

Uses

Used in Pharmaceutical Research and Development:
1-(4-Cyanophenyl)-1H-pyridin-2-one is used as a chemical compound in pharmaceutical research and development for its potential applications in medicine and drug discovery.
Used in Anti-inflammatory and Analgesic Applications:
In the medical field, 1-(4-Cyanophenyl)-1H-pyridin-2-one is used as an anti-inflammatory and analgesic agent, demonstrating its potential to alleviate pain and reduce inflammation.
Used in Medicinal Chemistry:
1-(4-Cyanophenyl)-1H-pyridin-2-one is used as a candidate for further exploration in medicinal chemistry, given its unique structure and potential bioactivity, making it an interesting target for the synthesis of related compounds for pharmaceutical purposes.

Check Digit Verification of cas no

The CAS Registry Mumber 444002-96-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,4,0,0 and 2 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 444002-96:
(8*4)+(7*4)+(6*4)+(5*0)+(4*0)+(3*2)+(2*9)+(1*6)=114
114 % 10 = 4
So 444002-96-4 is a valid CAS Registry Number.
InChI:InChI=1/C12H8N2O/c13-9-10-4-6-11(7-5-10)14-8-2-1-3-12(14)15/h1-8H

444002-96-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(2-oxopyridin-1-yl)benzonitrile

1.2 Other means of identification

Product number -
Other names 1-(4-cyanophenyl)-1H-pyridin-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:444002-96-4 SDS

444002-96-4Relevant articles and documents

Rhodium(III)-Catalyzed Annulation of Pyridinones with Alkynes via Double C-H Activation: A Route to Functionalized Quinolizinones

Li, Juan,Yang, Yudong,Wang, Zhigang,Feng, Boya,You, Jingsong

supporting information, p. 3083 - 3086 (2017/06/23)

A Rh(III)-catalyzed oxidative annulation of pyridin-2(1H)-ones with alkynes via double C-H activation to produce highly functionalized 4H-quinolizin-4-ones is disclosed. This reaction features easily available starting materials, simple manipulation, a relatively wide substrate scope, and good functional group tolerance. The application of this protocol is demonstrated by the synthesis of a known fluorescent quinolizino[3,4,5,6-ija]quinolinium salt.

Iron-catalyzed regioselective direct arylation at the C-3 position of N-alkyl-2-pyridone

Modak, Atanu,Rana, Sujoy,Maiti, Debabrata

, p. 296 - 303 (2016/09/09)

A number of pharmaceutical compounds possess an arylated 2-pyridone moiety. The existing reports using expensive starting materials and/or superstoichiometric metal salts have prompted us to explore a possible user-friendly method for their synthesis. In this report, we demonstrate an easy-to-handle reaction condition with an iron catalyst for the exclusive generation of C-3-arylated pyridone via C-H functionalization.

PROLINE DERIVATIVES

-

Page/Page column 38, (2008/06/13)

The invention relates to novel compounds of formula (I), wherein X, Y, R1, R2, R3, R4 and n have the meaning cited in claim 1, are inhibitors of the coagulation factor Xa and can be used for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours.

FACTOR XA INHIBITORS

-

Page/Page column 193-194, (2008/06/13)

The present invention is directed to compounds represented by Formula I and pharmaceutically acceptable salts, solvates, hydrates, and prodrugs thereof which are inhibitors of Factor Xa. The present invention is also directed to and intermediates used in making such compounds, pharmaceutical compositions containing such compounds, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.

An improved Ullmann-Ukita-Buchwald-Li conditions for CuI-catalyzed coupling reaction of 2-pyridones with aryl halides

Wang, Po-Shih,Liang, Chih-Kai,Leung, Man-Kit

, p. 2931 - 2939 (2007/10/03)

An effective CuI-trans-N,N′-dimethylcyclohexane-1,2-diamine (DMCDA)-K2CO3-catalyzed coupling reaction of 2-pyridones with aryl halides is described. Under our conditions, DMCDA was found to be an effective catalyst that facilitates the coupling reactions even in toluene, a common industrial solvent. In addition, 3-bromopyridine could also be coupled effectively under these conditions, indicating that the catalytic reactivity of this system is high. The reaction could be applied for polymer modification and iterative oligo-pyridone synthesis.

Phenyl derivatives

-

, (2008/06/13)

Novel compounds of the formula I in which W, X, Y, T, R1 and R2 are as defined in Patent claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 444002-96-4